Immune responses against the hepatitis C virus and the outcome of therapy
The hepatitis C virus (HCV) sets up persistence in the majority of those infected. In doing so, it evades both innate and adaptive immune responses. However, in a reasonable fraction of patients (20-50%), there is long-term control of viremia through some effective combination of host responses. It...
| Автори: | , |
|---|---|
| Формат: | Journal article |
| Мова: | English |
| Опубліковано: |
Springer New York
2008
|